Elisabetta Marini

1.5k citations

56 papers · 1.3k indexed · h-index 21

Co-authors: Marta Giorgis Massimo Bertinaria Loretta Lazzarato Barbara Rolando Roberta Fruttero Alberto Gasco Clara Cena Mattia Cocco
Topics: Inflammasome and immune disorders (8 papers)Nitric Oxide and Endothelin Effects (7 papers)Eicosanoids and Hypertension Pharmacology (7 papers)
Cited by: Biochemistry Nephrology Pharmaceutical Science
Journals: Journal of Medicinal Chemistry The Journal of Organic Chemistry Chemistry - A European Journal
Partner nations: Italy Switzerland United Kingdom

In The Last Decade

Elisabetta Marini

54 papers receiving 1.3k citations

Peers

Countries citing papers authored by Elisabetta Marini

Since Specialization

Citations

This map shows the geographic impact of Elisabetta Marini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Marini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Marini more than expected).

Fields of papers citing papers by Elisabetta Marini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabetta Marini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Marini. The network helps show where Elisabetta Marini may publish in the future.

Co-authorship network of co-authors of Elisabetta Marini

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabetta Marini. A scholar is included among the top collaborators of Elisabetta Marini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabetta Marini. Elisabetta Marini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Galactose: A Versatile Vector Unveiling the Potentials in Drug Delivery, Diagnostics, and Theranostics 2024 ·Pharmaceuticals ·(unknown),(unknown),(unknown),(unknown),Maria Nieddu,(unknown),Elisabetta Marini,Stefania Albrizio,Federica Sodano,Maria Grazia Rimoli	13
2	Concanavalin a Grafted Nanoemulsions for Nasal Delivery: Preliminary Studies with Fluorescently Labelled Formulations 2024 ·Materials ·(unknown),(unknown),(unknown),(unknown),Luca Ferraris,Elisabetta Marini,Elisabetta Muntoni,Maria Teresa Capucchio,Anna Scomparin,Luigi Battaglia	2
3	Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage 2023 ·Antioxidants ·Elisabetta Marini,Barbara Rolando,Federica Sodano,(unknown),(unknown),Stefano Guglielmo,Loretta Lazzarato,Konstantin Chegaev	8
4	Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 2022 ·Molecules ·Elisabetta Marini,Marco Marino,(unknown),Federica Maione,(unknown),Daniele Oddo,Marta Giorgis,Barbara Rolando,(unknown),(unknown),Serena Marchiò,(unknown),Francesca Spyrakis,Eleonora Gianquinto,Federica Di Nicolantonio,Massimo Bertinaria	8
5	Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor 2021 ·Molecules ·(unknown),Valentina Boscaro,Eleonora Gianquinto,Christina F. Sandall,Marta Giorgis,Elisabetta Marini,(unknown),(unknown),Francesca Spyrakis,Justin A. MacDonald,Massimo Bertinaria	10
6	Tuning NO release of organelle-targeted furoxan derivatives and their cytotoxicity against lung cancer cells 2021 ·Bioorganic Chemistry ·Federica Sodano,Elena Gazzano,Barbara Rolando,Elisabetta Marini,Loretta Lazzarato,Roberta Fruttero,Chiara Riganti,Alberto Gasco	11
7	Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms 2020 ·Nutrition Metabolism and Cardiovascular Diseases ·Elisabetta Muntoni,(unknown),Paola Milla,Elisabetta Marini,Chiara Ferraris,Maria Teresa Capucchio,Elena Colombino,Lorena Segale,Massimo Porta,Luigi Battaglia	20
8	Lipid nanoparticles as vehicles for oral delivery of insulin and insulin analogs: preliminary ex vivo and in vivo studies 2019 ·Acta Diabetologica ·Elisabetta Muntoni,Elisabetta Marini,Nahid Ahmadi,Paola Milla,Corrado Ghé,Alessandro Bargoni,Maria Teresa Capucchio,Elena Biasibetti,Luigi Battaglia	35
9	A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 2018 ·Frontiers in Pharmacology ·Carolina Pellegrini,Matteo Fornai,Rocchina Colucci,Laura Benvenuti,Vanessa D’Antongiovanni,Gianfranco Natale,Federica Fulceri,Marta Giorgis,Elisabetta Marini,(unknown),Massimo Bertinaria,Corrado Blandizzi,Luca Antonioli	43
10	Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid 2018 ·European Journal of Medicinal Chemistry ·Agnese Chiara Pippione,(unknown),Davide Bonanni,Marcella Sini,Parveen Goyal,Elisabetta Marini,Klaus Pors,Salvatore Adinolfi,Daniele Zonari,Claudio Festuccia,Weixiao Yuan Wahlgren,Rosmarie Friemann,Renzo Bagnati,Donatella Boschi,Simonetta Oliaro‐Bosso,Marco L. Lolli	40
11	Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors 2017 ·European Journal of Medicinal Chemistry ·Sandra Atlante,Konstantin Chegaev,Chiara Cencioni,Stefano Guglielmo,Elisabetta Marini,Emily Borretto,Carlo Gaetano,Roberta Fruttero,Francesco Spallotta,Loretta Lazzarato	17
12	NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease 2015 ·Bioorganic & Medicinal Chemistry ·Konstantin Chegaev,(unknown),Elisabetta Marini,Barbara Rolando,Roberta Fruttero,Michela Morbin,Giacomina Rossi,Valeria Fugnanesi,Antonio Bastone,Mario Salmona,(unknown),Laura Gasparini,Sara Cocco,Cristian Ripoli,Claudio Grassi,Alberto Gasco	20
13	Design, Synthesis and Pharmacological Evaluation of Anti-Pyroptotic Compounds Acting on NLRP3 Inflammasome Signaling Pathway: a New Start for Anti-Inflammatory Drugs? 2014 ·Pharmacology ·Massimo Bertinaria,Mattia Cocco,Davide Garella,Elisabetta Marini,Antonella Di Stilo,Gianluca Miglio	1
14	Synthesis and preliminary biological profile of new NO-donor tolbutamide analogues 2012 ·Bioorganic & Medicinal Chemistry Letters ·Yasinalli Tamboli,Loretta Lazzarato,Elisabetta Marini,Stefano Guglielmo,Michela Novelli,Pascale Beffy,Pellegrino Masiello,Roberta Fruttero,Alberto Gasco	22
15	Carnosine analogues containing NO-donor substructures: Synthesis, physico-chemical characterization and preliminary pharmacological profile 2012 ·European Journal of Medicinal Chemistry ·Massimo Bertinaria,Barbara Rolando,Marta Giorgis,(unknown),Elisabetta Marini,Massimo Collino,Elisa Benetti,Pier Giuseppe Daniele,Roberta Fruttero,Alberto Gasco	13
16	Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin‐Like Molecules that Covalently Inactivate Cyclooxygenase‐1 2011 ·ChemMedChem ·Clara Cena,Paolo Tosco,Elisabetta Marini,Loretta Lazzarato,Marco Piccinini,Cristina Ramondetti,Elisa Lupino,Roberta Fruttero,Alberto Gasco	7
17	Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties 2008 ·Bioorganic & Medicinal Chemistry ·Clara Cena,Konstantin Chegaev,Silvia Balbo,Loretta Lazzarato,Barbara Rolando,Marta Giorgis,Elisabetta Marini,Roberta Fruttero,Alberto Gasco	16
18	NO‐donor melatonin derivatives: synthesis and in vitro pharmacological characterization 2007 ·Journal of Pineal Research ·Konstantin Chegaev,Loretta Lazzarato,Barbara Rolando,Elisabetta Marini,Paolo Tosco,Clara Cena,Roberta Fruttero,Francesca Bertolini,Marianne Reist,Pierre‐Alain Carrupt,Valeria Lucini,F. Fraschini,Alberto Gasco	12
19	Amphiphilic NO‐Donor Antioxidants 2006 ·ChemMedChem ·Konstantin Chegaev,Loretta Lazzarato,Barbara Rolando,Elisabetta Marini,Gloria V. López,Massimo Bertinaria,Antonella Di Stilo,Roberta Fruttero,Alberto Gasco	1
20	A new class of NO-donor H3-antagonists 2004 ·Il Farmaco ·Paolo Tosco,Massimo Bertinaria,Antonella Di Stilo,Elisabetta Marini,Barbara Rolando,Giovanni Sorba,Roberta Fruttero,Alberto Gasco	7

About Elisabetta Marini

Elisabetta Marini is a scholar working on Biochemistry, Pharmaceutical Science and Nephrology, having authored 56 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). The work is most often cited by research in Biochemistry (107 citations), Nephrology (96 citations) and Pharmaceutical Science (79 citations). Elisabetta Marini has collaborated with scholars based in Italy, Switzerland and United Kingdom. Frequent co-authors include Marta Giorgis, Massimo Bertinaria, Loretta Lazzarato, Barbara Rolando, Roberta Fruttero, Alberto Gasco, Clara Cena, Mattia Cocco, Gianluca Miglio and Konstantin Chegaev. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Chemistry - A European Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact